Acotec Scientific Holdings Limited provided revenue guidance for the year ended December 31, 2021. For the period the Group expects to record: revenue of approximately RMB 300 million to RMB 303 million, representing an increase of approximately 54.7% to 56.2% as compared to that of the year ended December 31, 2020.
Acotec Scientific Holdings Limited
Equities
6669
KYG0096M1096
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.97 HKD | +3.64% |
|
+17.90% | -29.34% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.34% | 320M | |
+75.69% | 12.57B | |
+7.45% | 6.69B | |
-28.45% | 6.98B | |
-19.73% | 4.63B | |
+17.40% | 4.18B | |
-21.37% | 3.81B | |
-25.83% | 2.8B | |
-1.24% | 2B | |
+14.74% | 1.84B |
- Stock Market
- Equities
- 6669 Stock
- News Acotec Scientific Holdings Limited
- Acotec Scientific Holdings Limited Provides Revenue Guidance for the Year Ended December 31, 2021